Brief: Elevation Oncology Appoints Julie Cherrington, Alan Sandler To Board
04/03/2024 12:36
March 4 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY APPOINTS EXPERIENCED CLINICAL
DEVELOPMENT
LEADERS JULIE CHERRINGTON, PH.D. AND ALAN SANDLER, M.D. TO BOARD
OF DIRECTORS
Source text for Eikon: ID:nPn21dTLGa
Further company coverage: ELEV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing